Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

October 31, 2004

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Atomoxetine Hydrochloride

DRUG

Methylphenidate Hydrochloride

Trial Locations (3)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Shanghai

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mexico City

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Seoul

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00486083 - Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD | Biotech Hunter | Biotech Hunter